1 / 2

Halberd (OTC: HALB) Receives Antibiotic Resistant Bacteria from The Centers

Halberd Corporation (OTC: HALB) has received from the CDC (Centers for Disease Control and Prevention) an array of antibiotic resistant bacteria (ARB) for Laser Eradication Tests.

thestreetreports
Download Presentation

Halberd (OTC: HALB) Receives Antibiotic Resistant Bacteria from The Centers

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Halberd (OTC: HALB) Receives Antibiotic Resistant Bacteria from The Centers of Disease Control (CDC) for Laser Eradication thestreetreports.com/halberd-otc-halb-receives-antibiotic-resistant-bacteria-from-the-centers-of-disease-control- cdc-for-laser-eradication Halberd Corporation (OTC: HALB) has received from the CDC (Centers for Disease Control and Prevention) an array of antibiotic resistant bacteria (ARB) for Laser Eradication Tests. One of the companies to have made significant strides in the field of healthcare over the course of the year so far is Halberd Corporation and it may be a good time to take a closer look into it. 1/2

  2. The company was in fact in the news earlier on in the month back on December 6 when it announced that it had received a range of antibiotic-resistant bacteria or ARB from the Centers for Disease Control and Prevention (CDC). The company announced that it was going to deploy its laser eradication technology on the ARB. It should be noted that back on October 18 this year, the company reported that its laser eradication technology had managed to eliminate Gram-Negative bacteria. Gram-Negative bacteria are well known for being particularly resistant to antibiotics and the latest development could help the company in reinforcing the effectiveness of its technology. The CDC is well-known for providing ARB samples to research organizations so as to promote the development of technologies and methods for the eradication and neutralization of such bacteria. The Chief Technology Officer of Halberd also spoke about the latest development. He noted that the company had managed to achieve encouraging results when dealing with the Shigella, Salmonella, and E. Coli bacteria. He went on to add that everyone at the company was excited at the possibility of testing of its technology on the latest group of ARB. On the other hand, the President, Chairman, and Chief Executive Officer of the company, William A Hartman emphasized that the fact that Halberd had been chosen by the CDC was in itself a milestone. He added that it was also an indication that the company’s technology was perhaps of interest to the United States government as well. It will be interesting to see if the Halberd stock gets any traction over the coming days or not. 2/2

More Related